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Objectives: To determine whether renal perfusion
with cold crystalloid solution enriched with histidine-tryp-
tophan-ketoglutarate (Custodiol) provides better protec-
tion against renal ischemic injury than cold lactated
Ringer’s solution in patients undergoing suprarenal aortic
aneurysm (sAAA) open repair.
Methods: We reviewed 256 consecutive patients un-
dergoing sAAA open repair between 1993 and 2013. In
181 cases, direct perfusion of at least one renal artery was
performed. Among these patients, 87 had cold renal perfu-
sion with Ringer’s lactate solution and 94 with Custodiol so-
lution. Propensity score matching based on baseline clinical
variables that were expected to inﬂuence renal outcomes was
performed to correct for any bias that may have been asso-
ciated with the use of Custodiol. Postoperative acute renal
dysfunction (ARD) stratiﬁed in ﬁve classes according to
postoperative serum creatinine elevation and need for dial-
ysis was compared in the two groups, and independent pre-
dictors of ARD were identiﬁed at multivariate analysis.
Results: After propensity score matching we were able
to match 74 Custodiol cases one-to-one to those receiving
perfusion with lactated Ringer’s solution. Overall 30-day
mortality was 3.4%, temporary hemodialysis or continuous
venovenous hemoﬁltration was 4.7%, and dialysis at
discharge was 2.7%. Freedom from ARD >2 (>100%
elevation in baseline ceratinine level) and from the need
for dialysis were signiﬁcantly increased in the Custodiol
group (P ¼ .007 and P ¼ .04, respectively). At multivariate
analysis, Custodiol perfusion and clamping time were the
independent predictors of non-ARD >2.
Conclusions: In this series of sAAA repair, perfusion
with (4C) Custodiol offered superior renal protection
when compared with (4C) Ringer’s lactate. Larger series
and/or randomized trials are needed to conﬁrm this ﬁnding.
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Objectives: To evaluate the level of endoleak and the
decrease in size of infrarenal abdominal aortic aneurysm
(AAA) after coil embolization during endovascular aneu-
rysm repair (EVAR) for patients at risk for type II
endoleak.
Methods: Between 2009 and 2013, 80 patients with
AAA and a high risk for type II endoleak were treated
with coil embolization of the aneurysm sac during EVAR.
Embolization was performed using a microcatheter placed
between the stentgraft and the aortic aneurysm wall.
Follow-up using computed tomography (CT) scans (ﬁrst
month, 6 months, 1 year, and 1 years) was obtained to eval-
uate presence of endoleaks and the size of the aneurysm sac.
Results: The mean number of coils used for emboliza-
tion was 11 (range, 8-14 coils). Technical success was achieved
in all patients. Only one of 80 patients (1.2%) presented a type
II endoleak on follow-up CT scans. Statistical analysis (paired
t-test) showed a signiﬁcant decrease of the aneurysm diameter
at 6 months (P ¼ .036), 1 year (P ¼ .004), and 2 years (P ¼
.001). The mean follow-up period after treatment was 13
months (range, 1-29 months). There were no procedure-
related complications and two secondary interventions.
Conclusions: Coil embolization of the aneurysm
sac during EVAR for patients at risk for type II endo-
leak is technically feasible and clinically effective in pre-
venting type II endoleak. This led to a rapid decrease in
size of AAA and low level of secondary intervention.
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Objectives: Ischemic colitis (IC) is a well-described
complication of ruptured abdominal aortic aneurysm
(rAAA). The objective of this study was to compare the
incidence of IC in patients with rAAA undergoing open
or endovascular aneurysm repair (EVAR), comparing the
preimplementation and postimplementation of a formal
rupture AAA protocol with modern methods of resuscita-
tion to include permissive hypotension.
Methods: Data on all patients presenting with rAAA
to our institution between Jan 1, 2002, and Oct 31,
2013, were collected. Data analyzed included prehospital
records, anesthesia reports, operative notes, preoperative
and intraoperative imaging, and outcomes. A database
with >37,000 variables was created and analyzed. The inci-
dence of IC with open compared with endovascular repair
was determined using Pearson c2 statistic with signiﬁcance
set at P < .05.
Results: During the study period, 303 patients pre-
sented with rAAA. Of these, 191 patients underwent
open repair, and 89 underwent EVAR. Twenty-three pa-
tients died in the emergency department, en route to the
operating room, or after choosing comfort care. The over-
all incidence of IC in this cohort was 16.4% (46 of 280). Of
the patients undergoing open repair vs EVAR, the rate ofTable. Demographics and outcomes for patients who underwe
Rupture EVAR Inhosp
Hospital Control
Government, nonfederal hospital 353 (12.3%)* 1889 (65.9%)* 1
Private, nonproﬁt hospital 2112 (9.7%)* 15196 (70.1%)* 10
Private, for-proﬁt hospital 277 (7.5%)* 2761 (75.0%)* 1
Hospital Be
Small 219 (9.3%) 1733 (73.5%)* 1
Medium 502 (9.5%) 3866 (72.9%)* 2
Large 2020 (9.8%) 14247 (69.3%)* 10
Hospital Lo
Rural 190 (9.9%) 1315 (68.4%)
Urban 2552 (9.7%) 18532 (70.4%) 13
Hospital Teach
Nonteaching 1051 (8.6%)* 8702 (71.4%)* 6
Teaching 1689 (10.5%)* 11150 (69.5%)* 8
Hospital R
Northeast 537 (9.8%) 4058 (74.0%)* 2
Midwest 705 (9.6%) 4932 (67.1%)* 3
South 975 (9.0%) 7771 (71.4%)* 4
West 554 (11.5%)* 3312 (68.5%)* 2
*P < .001.
zP < .05IC was 44% (40 of 191) vs 6.7% (6 of 89; P ¼ .03). During
the study period, no statistical difference was noted in 30-
day mortality for patients with IC between the open (55%
[22 of 40]) and EVAR groups (33% [two of six]; P ¼ .32).
Rates of IC before and after implementation of our formal
rupture protocol in 2007 were compared. Before July
2007, the rate of IC was 37.1% (36 of 97). With the pro-
tocol in place, the rate of IC decreased to 6.4% (10 of 157;
P ¼ .000).
Conclusions: With the emergence of EVAR for rAAA,
the incidence of ischemic colitis has decreased signiﬁcantly.
However, ischemic colitis continues to portend a poor prog-
nosis after any type of repair. We believe that modern
methods of resuscitation to include permissive hypotension
are related to this decreased rate of ischemic colitis.
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Objectives: The aim of this paper is to use a national
inpatient database to identify variables that impact mortal-
ity after elective and ruptured abdominal aortic aneurysm
(AAA) repair.
Methods: The National Inpatient Sample was used
from 2000 to 2010, and ICD-9 codes for AAA repair
used for elective and ruptured cases. Clinical covariates
included type of repair, inhospital mortality, total charges
converted to 2010 U.S. dollars. Hospital covariates
included hospital ownership, size, location (rural vs urban),
teaching status, and region.nt AAA repair in the NIS from 2000-2010
ital Mortality Emergency Admission LOS Total Charges
DRG Risk
of Mortality
/Ownership
72 (6.0%)z 860 (30.0%) 3 $79498 2.12*
84 (5.0%)z 4984 (23.0%) 3 $75535 2.04*
47 (4.0%)z 1102 (30.0%) 3 $98416* 1.94*
d Size
41 (5.0%) 542 (23.0%) 2 $68241* 1.98
65 (5.0%) 1217 (23.0%) 2 $76886* 1.99*
28 (5.0%) 5140 (25%)z 3 $80260* 2.05*
cation
96 (5.0%) 519 (27.0%)z 3 $62444* 1.99
15 (5.0%) 6308 (24.0%)z 3 $79838* 2.04
ing Status
09 (5.0%) 3044 (25.0%) 3 $78,262 1.99*
02 (5.0%) 3848 (24.0%) 3 $78,670 2.07*
egion
74 (5.0%) 1259 (23.0%) 3 $73,385 2.03
67 (5.0%) 1616 (22.0%)* 3 $72,280 2.05
35 (4.0%)z 675 (27.0%)* 3 $78,646 1.99*
90 (6.0%)z 1209 (25.0%)* 3 $100,288* 2.11*
